HJC0152   Click here for help

GtoPdb Ligand ID: 12140

Synonyms: compound 11 [PMID: 23459613] | compound 11 [WO2014113467A1] | HJC-0152 | HJC-1-52 [3]
Compound class: Synthetic organic
Comment: HJC0152 was originally identified as an orally bioavailable compound with anti-cancer properties [1], and weak anti-viral activity [2]. Its chemical structure is based upon that of the signal transducer and activator of transcription 3 (STAT3)-inhibiting compound niclosamide. STAT3 is an oncology drug target, since excessive activation of STAT3 occurs in cancers, and is a perdictor of poor prognosis. Blocking STAT3 signalling in many cancer cell types induces growth arrest and promotes apoptosis. To mour knowledge there is no quantitative data that supports the direct interaction of HJC0152 with STAT3.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 7
Topological polar surface area 107.49
Molecular weight 369.03
XLogP 3.27
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES NCCOc1ccc(cc1C(=O)Nc1ccc(cc1Cl)[N+](=O)[O-])Cl
Isomeric SMILES NCCOc1c(cc(Cl)cc1)C(=O)Nc1c(Cl)cc(cc1)[N+](=O)[O-]
InChI InChI=1S/C15H13Cl2N3O4/c16-9-1-4-14(24-6-5-18)11(7-9)15(21)19-13-3-2-10(20(22)23)8-12(13)17/h1-4,7-8H,5-6,18H2,(H,19,21)
InChI Key DIMJVBOEXNWPOG-UHFFFAOYSA-N
Bioactivity Comments
HJC0152 reduces levels of total STAT3 and Tyr705-phosphorylated STAT3, and inhibits IL-6-induced pSTAT3 nuclear translocation in vitro [3]. Orally administered HJC0152 inhibits the growth of MDA-MD-231 cell xenograft tumours in mice.

Biological data for HJC0152 is likely to have been generated using the hydrochloride salt.